Use of MR spectroscopy and functional imaging in the treatment planning of gliomas

British Journal of Radiology

Volumn 80, Issue 953, 2007, Pages 347-354

  Narayana, Ashwatha ^a,b   Chang, J ^a   Thakur, S ^a   Huang, W ^a   Karimi, S ^a   Hou, B ^a   Kowalski, A ^a   Perera, G ^a   Holodny, A ^a   Gutin, P H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE;

ANATOMICAL VARIATION; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOMA; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME;

BRAIN; BRAIN NEOPLASMS; CHOLINE; CRANIAL IRRADIATION; CREATINE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 34548251419     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/65349468     Document Type: Article

References (22)

1. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high grade astrocytoma: a Medical Research Council trial. J Clin Oncol 2001;19:509-18.
2. Shaw EG, Stieber V, Tatter S, Ellis T, Hinson W, Kearns W, et al. A Phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM). Int J Radiat Oncol Biol Phys 2002;54:206, Abstract.
3. Wallner KE. Radiation therapy treatment planning for malignant astrocytomas. Semin Radiat Oncol 1991;1:17-25.
4. Thornton AF Jr. Sandler HM, Ten Haken RK, McShawn DL, Fraass BA, La Vigne ML, et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 1992;24:767-75.
5. Byrne TN. Imaging of gliomas. Semin Oncol 1994;21:162-71.
6. Duijn JH, Matson GB, Maudsley AA, Weiner MW. 3D phase encoding 1H spectroscopic imaging of human brain. Magn Reson Imaging 1992;10:315-19.
7. Moonen CT, von Kienlin M, van Zijl PC, Cohen J, Gillen J, Daly P, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2:201-8.
8. De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44:273-8.
9. Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001;50:915-28.
10. Moonen CTW, Bandettini PA, editors. Functional MRI. Berlin, Germany: Springer, 1999.
11. Liu WC, Schulder M, Narra V, Kalnin AJ, Kathcart C, Jacobs A, et al. Functional magnetic resonance imaging aided radiation treatment planning. Med Phys 2000;27:1563-72.
12. Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S, et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 2006;33:32-40.
13. Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79-88.
14. Earnest F 4th, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT-contrast enhancement with stereotaxic biopsy. Radiology 1998;166:823-7.
15. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002;97:794-802.
16. Narayana A, Leibel SA. Adult brain tumors. In: Leibel SA, Philips TL, editors. Textbook of radiation oncology, 2nd edn. Philadelphia, PA: Saunders, 2004:463-95.
17. Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Grave EE, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002;53:1254-64.
18. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumor Working Party. Br J Cancer 1991;64:769-74.
19. Hunt MA, Zelefsky MZ, Wolden S, Chin CS, LoSasso T, Rosenzweig K, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-32.
20. Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002;52:599-605.
21. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31:983-8.
22. Narayana A, Yamada Y, Hunt M, Shah P, Gutin PH, Leibel SA. Intensity modulated radiotherapy in high grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys 2006;64:892-7.